Sundaram Preethi Insider Trades

Insider Trading History

Track insider trading activity for Sundaram Preethi. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $25M 798,437 shares
Last Trade
Dec 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$160k 6,667 shares
$24.06
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.79M 57,173 shares
Last Trade
Dec 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$160k 6,667 shares
$24.06
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.71M 54,804 shares
Last Trade
Dec 29, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$57k 2,369 shares
$24.06
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $25.2M 805,104 shares
Last Trade
Dec 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$161k 6,855 shares
$23.53
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.63M 52,175 shares
Last Trade
Dec 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$161k 6,855 shares
$23.53
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.58M 50,506 shares
Last Trade
Dec 08, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$39.3k 1,669 shares
$23.53
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.42M 45,320 shares
Last Trade
Nov 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$31.8k 1,364 shares
$23.28
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $25.4M 811,959 shares
Last Trade
Nov 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$130k 5,603 shares
$23.28
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.46M 46,684 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$130k 5,603 shares
$23.28
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $25.6M 817,562 shares
Last Trade
Nov 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.17M 139,130 shares
$22.77
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.29M 41,081 shares
Last Trade
Jun 11, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.3k 1,600 shares
$26.42
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.34M 42,681 shares
Last Trade
Jun 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$61.4k 2,324 shares
$26.41
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $21.2M 678,432 shares
Last Trade
Feb 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$388k 16,667 shares
$23.27
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.59M 50,970 shares
Last Trade
Feb 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$388k 16,667 shares
$23.27
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.41M 45,005 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$139k 5,965 shares
$23.27
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.07M 34,303 shares
Last Trade
Dec 27, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$50.3k 2,345 shares
$21.47
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.15M 36,648 shares
Last Trade
Dec 27, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 6,667 shares
$21.47
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $21.7M 695,099 shares
Last Trade
Dec 27, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 6,667 shares
$21.47
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $1.01M 32,396 shares
Last Trade
Dec 09, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$149k 6,855 shares
$21.74
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Strategy Officer
Holding Value $22M 701,766 shares
Last Trade
Dec 09, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$149k 6,855 shares
$21.74
$31.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up